BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    

Zimmer (ZMH) Introduces V2F™ Anterior Fixation System for the Treatment of Spinal Tumor and Trauma Pathology

1/22/2013 9:31:28 AM

MINNEAPOLIS, Minn., Jan. 21, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, today introduced the Zimmer V2F Anterior Fixation System, a new implant system for the treatment of thoracolumbar burst fractures, tumors, disc degeneration and other pathologies of the anterior spine. The system represents Zimmer's first lateral plate system for the spinal trauma segment.

The V2F System consists of a wide range of plates and screws designed to better match the varying anatomy of the thoracolumbar spine. Leveraging a proprietary technology developed by Zimmer's Trauma business, the V2F System incorporates variable-to-fixed locking cap technology, which enables surgeons to place screws at variable angles and to lock screw trajectory to the plate rigidly, or semi-constrained. This flexibility to place screws with variability of up to 15 degrees in any direction allows surgeons to avoid critical anatomical structures and better fit the existing anatomical structure.

"Tumor and trauma pathology of the spine can result in complex anatomical challenges for surgeons," said Steve Healy, President of Zimmer Spine. "By incorporating novel variable-to-fixed screw and cap technology, the Zimmer V2F Anterior Fixation System offers surgeons greater flexibility to address the unique anatomy of every patient through variable screw and plate placement and fixation."

Designed to facilitate efficiency without compromising control or strength, the Zimmer V2F Anterior Fixation System features All-Through-One Instrumentation to guide efficient screw placement and 6mm and 7mm dual-lead screws to provide enhanced insertion speed and bone screw fixation.

About Zimmer
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2011 sales were approximately $4.5 billion. The Company is supported by the efforts of more than 8,500 employees worldwide. For more information, please visit our website at

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE Zimmer Holdings, Inc.

Read at